ERBB2 and ductal breast carcinoma in situ: In this study, there was a steady increase in the proportion of ER-positive DCIS over time, which was correlated with lower rate of HER2 positivity and higher rate of breast conservation as the primary option of DCIS management as illustrated in Fig. 1.